Livas 1 and others. Just take you back to the placement made at 1 cent last year and the comment made by Andre Marschke. This is obviously why Scintilla continue to buy this stock. Only around 250 million shares on issue and planning to be cash flow positive by the end of 2008. Watch this Company as I truely believe it'll be well north of current levels in 6 to 12 months time.
“Argus and the original developers of Cornerstone have spent more than four years and in excess of $5m to develop this flagship product and Scintilla recognises the inherent
value in the technology and its worldwide applications.”
Scintilla’s Managing Director Andre Marschke stated that “Development and discovery spend has largely ceased and Argus is now in the exciting position of marketing its
exceptional Cornerstone offering to the international marketplace. Recent contract wins in the United Kingdom highlights the fact that Argus software is gaining significant
traction and acceptance amongst key government customers.”
Argus welcomes the Scintilla investment.
- Forums
- ASX - By Stock
- ASV
- asv set to travel higher over the next 12 mths
asv set to travel higher over the next 12 mths
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ASV (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 200000 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 25950 | 1 |
Last trade - 07.00am 25/11/2024 (20 minute delay) ? |
Featured News
ASV (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online